# Surgical management of lobar cerebral cavernous malformations in children: a single-center experience

**Authors:** Ryszard Sordyl, Lukasz Antkowiak, Marta Rogalska, Michael Schroter, Izabela Rosol, Marcin Ciekalski, Antonina Radolinska, Marek Mandera

PMC · DOI: 10.1007/s00381-024-06433-5 · 2024-05-07

## TL;DR

This study examines the safety and outcomes of surgically removing lobar cerebral cavernous malformations in children.

## Contribution

The paper provides a single-center experience on surgical indications and outcomes for pediatric lobar CCMs.

## Key findings

- Surgery led to symptom resolution in all patients with seizures or neurological deficits.
- Drug-resistant epilepsy improved significantly post-surgery.
- No surgery-related complications were observed in the 52-month follow-up.

## Abstract

We aimed to determine the surgical indications and postoperative outcomes among pediatric patients with lobar cerebral cavernous malformations (CCMs).

We retrospectively reviewed pediatric patients operated on for lobar CCM between March 2010 and August 2021. Indications for surgery included (1) intracranial hemorrhage, (2) symptomatic superficially located lesion, and (3) asymptomatic CCM in non-eloquent area in case of strong parental preferences. Patients presenting with seizures were assessed using Engel Epilepsy Surgery Outcome Scale.

Twenty-one patients were included. The predominant symptoms were seizures (57.1%), headaches (33.3%), and focal neurological deficits (23.8%). Patients were qualified for surgery due to symptomatic intracranial hemorrhage (47.6%), drug-resistant epilepsy (28.6%), and focal neurological deficits (9.5%). Three patients (14.3%) were asymptomatic. A gross total resection of CCM with the surrounding hemosiderin rim was achieved in all patients. The mean follow-up was 52 months. No patient experienced surgery-related complications. In all individuals with a preoperative first episode of seizures or focal neurological deficits, the symptoms subsided. All six patients with drug-resistant epilepsy improved to Engel classes I (67%) and II (33%).

Surgical removal of symptomatic lobar CCMs in properly selected candidates remains a safe option. Parental preferences may be considered a sole qualifying criterion for asymptomatic lobar CCM excision.

## Linked entities

- **Diseases:** cerebral cavernous malformations (MONDO:0020724)

## Full-text entities

- **Diseases:** Epilepsy (MESH:D004827), seizures (MESH:D012640), CCM (MESH:D020786), headaches (MESH:D006261), intracranial hemorrhage (MESH:D020300), drug-resistant epilepsy (MESH:D000069279), focal neurological deficits (MESH:D009461)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11269512/full.md

---
Source: https://tomesphere.com/paper/PMC11269512